Is antiviral dual therapy the right approach to treating mpox in immunocompromised patients? Discussion following a case report

CMI Communications 2026 Open access

Read full text
Authors: Etienne Marquet, Quentin Le Hingrat, Lila Delobal, Gilles Peytavin, Jonathan Marie, Thomas Bénéteau, C. Rioux, Claire Amaris Hobson, Morgane Mailhe, Alexandra Calmy, Jade Ghosn, Yazdan Yazdanpanah
+1 more François-Xavier Lescure
DOI: 10.1016/j.cmicom.2026.105187
Cited by: 0
References: 27

Abstract

A 30-year-old man with CDC stage C HIV infection, initially diagnosed due to cerebral toxoplasmosis, and a 5-year history of CD4 counts

Fields of Study & Subjects

Poxvirus research and outbreaks Herpesvirus Infections and Treatments Virology and Viral Diseases

Publication details

Journal / source
CMI Communications
Volume
3
Issue
2
Pages
105187–105187
Publication date
15 March 2026
Language
EN